
Sanofi to Support BioNTech in Manufacturing Their COVID-19 Vaccine
From summer 2021, Sanofi will perform late-stage manufacturing to supply over 125 million doses of vaccine for the EU

Open Innovation for Global Health
With blockbuster drugs falling off the patent cliff, open innovation is being hailed as the key element to drive future success

First Quarter Results 2011
The first quarter results show a promising start to 2011 for the chemical industry

Top 20 Biopharma Employers
20 biopharma companies with the best reputations as employers in 2010